The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 133.00
High: 133.00
Low: 133.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Results of BoE Stress Test 2022

12 Jul 2023 07:30

RNS Number : 6938F
Nationwide Building Society
12 July 2023
 

Nationwide Building Society ("Nationwide")

Embargoed to 7.30am on 12 July 2023

NATIONWIDE'S RESPONSE TO THE RESULTS OF THE BANK OF ENGLAND STRESS TEST 2022

 

Today the Bank of England issued the results of its latest Concurrent Stress Test. The specified hypothetical Annual Cyclical Scenario (ACS) 2022 considered a 31% fall in house prices, 8.5% peak in unemployment and Bank Base Rate peak of 6% in the first year of the scenario.

 

The results of ACS 2022 confirm that Nationwide would remain profitable in such conditions and continue to make full distributions on all Tier 1 capital instruments, with a minimum stressed CET1 ratio of 20.4%, and a minimum UK leverage ratio of 5.6%, after the application of management actions. In each case the Society remains substantially above the regulatory hurdle rates set for this stress test of 7.4% CET1 ratio and 3.6% UK leverage ratio, both before and after the application of management actions.

 

The PRA has confirmed that Nationwide is not required to submit a revised capital plan or take additional actions as a result of this stress test exercise.

 

As in the stress testing exercises completed in previous years, the CET1 ratio reduces primarily due to the impact of the significant house price reduction, rising interest rate environment and increase in unemployment rate on model risk weights, rather than capital losses.

 

The CST 2022 exercise was modelled using currently approved mortgage models with the June 2022 start point reflecting a temporary model adjustment applied to risk weighted assets to ensure outcomes are consistent with the PRA's revised IRB regulations which became effective on 1 January 2022 (for more information see Nationwide Pillar 3 disclosures). These regulations aim to increase consistency of approaches across different firms and reduce volatility of mortgage risk weights across differing economic conditions. As expected, this has significantly reduced the extent to which risk weighted assets (RWA) increase in ACS 2022 given the higher RWA start point.

 

Nationwide recognises the value of industry-wide stress testing and continues to support the financial stability objectives of the Financial Policy Committee and the Bank of England.

 

On 19 May, Nationwide issued its full-year results for the period 5 April 2022 to 4 April 2023. These results reflected the continued capital strength and security of the business with a CET1 ratio of 26.5% (4 April 2022: 24.1%) and leverage ratio of 6.0% (4 April 2022: 5.4%).

 

Contacts:

Media Queries:

Sara Batchelor

Media Relations

T: +44 (0)7785 344 137

Sara.Batchelor@nationwide.co.uk

 

Investor Queries:

Sarah Abercrombie

Head of Investor Relations, Credit Ratings and Treasury Sustainability

T: +44 (0)7587 886 500

Sarah.Abercrombie@nationwide.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPGPUAWMUPWGCG
Date   Source Headline
5th Aug 20222:47 pmRNSPublication of Final Terms
5th Aug 20222:46 pmRNSPublication of Final Terms
26th Jul 20222:53 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
14th Jul 20223:43 pmRNSResult of AGM
12th Jul 20229:29 amRNSPre Stabilisation Notice - Nationwide Building Soc
24th Jun 202210:45 amRNSPublication of a Prospectus
10th Jun 20227:30 amRNSResolvability Assessment Framework
9th Jun 20224:56 pmRNSFurther re Tender Offer
25th May 20223:01 pmRNSTender Offer
20th May 202212:44 pmRNSPublication of Supplemental Prospectus
20th May 20227:00 amRNSAnnual Financial Report
16th May 20222:21 pmRNSPublication of Final Terms
26th Apr 20226:00 pmRNSPublication of Final Terms
5th Apr 20224:10 pmRNSRedemption of Notes
1st Apr 20229:00 amRNSDirectorate Change
1st Mar 20229:00 amRNSBoard Changes
25th Feb 20223:19 pmRNSPublication of a Prospectus
15th Feb 20229:23 amRNSPublication of Final Terms
15th Feb 20229:23 amRNSPublication of Final Terms
28th Jan 20228:00 amRNSBoard Changes
14th Dec 20217:00 amRNSResponse to Results of BoE Stress Test 2021
10th Dec 20211:51 pmRNSPublication of Base Prospectus
10th Dec 20211:41 pmRNSPublication of Base Prospectus
3rd Dec 20218:00 amRNSLeadership Succession
19th Nov 202111:13 amRNSPublication of Suppl.Prospcts
19th Nov 20217:00 amRNSHalf-year Report
29th Oct 20213:34 pmRNSPublication of a Prospectus
19th Oct 20217:00 amRNSPermanent Interest Bearing Shares Call Notice
11th Oct 20214:23 pmRNSPublication of Final Terms
23rd Sep 20219:00 amRNSLeadership Succession
10th Sep 20215:36 pmRNSPublication of Final Terms
22nd Jul 20212:49 pmRNSResults of AGM and Board changes
7th Jul 20211:57 pmRNSResult of Meeting
29th Jun 202112:15 pmRNSPublication of a Base Prospectus
3rd Jun 202111:00 amRNSCirc re. Notice of Meeting
3rd Jun 202110:59 amRNSTender Offer and Consent Solicitation
24th May 20211:53 pmRNSPublication of Suppl.Prospcts
21st May 20217:00 amRNSAnnual Financial Report
5th May 20212:06 pmRNSPublication of Final Terms
1st Apr 20219:46 amRNSPublication of Suppl.Prospcts
1st Mar 20216:05 pmRNSPublication of Final Terms
1st Mar 20211:00 pmRNSAppointment of Non-Executive Director
12th Feb 20216:03 pmRNSPublication of a Prospectus
22nd Jan 202110:39 amRNSPublication of Final Terms
7th Jan 202112:32 pmRNSPublication of a Prospectus
16th Dec 202010:33 amRNSPublication of Final Terms
8th Dec 202012:47 pmRNSHolding(s) in Company
8th Dec 202012:46 pmRNSInitial admission - Offcl Lst

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.